Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients
Phase 2
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: nutritional supplementationBehavioral: exercise
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 19
- Registration Number
- NCT00179218
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Hepatocellular Research Registry
- Conditions
- Hepatocytes
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 200
- Registration Number
- NCT00178893
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients
Phase 2
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: nutritional supplementationBehavioral: exercise
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-05-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 26
- Registration Number
- NCT00179140
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
Phase 3
Completed
- Conditions
- Unipolar Depression
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 30
- Registration Number
- NCT00179244
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Nitric Oxide and the Autonomic Nervous System
Not Applicable
Completed
- Conditions
- HypertensionPure Autonomic Failure
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 112
- Registration Number
- NCT00178919
- Locations
- 🇺🇸
Autonomic Dysfunction Center, Nashville, Tennessee, United States
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
Completed
- Conditions
- Hematopoietic Stem Cell TransplantationGraft vs Host Disease
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-12-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 100
- Registration Number
- NCT00179049
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
Completed
- Conditions
- Hematopoietic Stem Cell TransplantationGraft vs Host Disease
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-12-15
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 100
- Registration Number
- NCT00179075
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
A National Registry of Patients With Hepatocellular Carcinoma
Completed
- Conditions
- Carcinoma, Hepatocellular
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-10-10
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 150
- Registration Number
- NCT00178867
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
Not Applicable
Completed
- Conditions
- SchizophreniaSchizoaffective DisorderDepressive Disorder, MajorBipolar Disorder
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-08-26
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 300
- Registration Number
- NCT00179062
- Locations
- 🇺🇸
Psychiatric Hospital at Vanderbilt, Nashville, Tennessee, United States
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
Phase 2
Terminated
- Conditions
- End Stage Renal Disease
- Interventions
- Drug: Nepro nutritional supplementDrug: placebo
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 27
- Registration Number
- NCT00179205
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States